These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22958860)
1. Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis. Contini P; Schiavina M; Schiavina R; Tavalazzi F; Fabiani A; Di Scioscio V; Spagnolo P; Richeldi L Multidiscip Respir Med; 2011 Oct; 6(5):313-7. PubMed ID: 22958860 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis. Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095 [TBL] [Abstract][Full Text] [Related]
4. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus. Sakaue T; Tominaga M; Niizeki T; Zaizen Y; Matsukuma K; Koganemaru M; Hoshino T; Torimura T Respir Med Case Rep; 2018; 23():86-89. PubMed ID: 29349035 [TBL] [Abstract][Full Text] [Related]
7. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750 [TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients. Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367 [TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor. Abdelkader A; Lam CA; Shahir KS; Christians K; Suster SM Ann Diagn Pathol; 2017 Apr; 27():69-73. PubMed ID: 28325364 [TBL] [Abstract][Full Text] [Related]
11. Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Harari S; Cassandro R; Chiodini I; Taveira-DaSilva AM; Moss J Chest; 2008 Feb; 133(2):448-54. PubMed ID: 18071009 [TBL] [Abstract][Full Text] [Related]
12. Primary retroperitoneal lymphangioleiomyomatosis in a postmenopausal woman: a case report and review of the literature. Kebria M; Black D; Borelli C; Modica I; Hensley M; Chi DS Int J Gynecol Cancer; 2007; 17(2):528-32. PubMed ID: 17362325 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status. Usuki J; Horiba K; Chu SC; Moss J; Ferrans VJ Arch Pathol Lab Med; 1998 Oct; 122(10):895-902. PubMed ID: 9786350 [TBL] [Abstract][Full Text] [Related]
14. Localized retroperitoneal lymphangioleiomyomatosis mimicking malignancy. A case report and review of the literature. Jaiswal VR; Baird J; Fleming J; Miller DS; Sharma S; Molberg K Arch Pathol Lab Med; 2003 Jul; 127(7):879-82. PubMed ID: 12823048 [TBL] [Abstract][Full Text] [Related]
15. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Logginidou H; Ao X; Russo I; Henske EP Chest; 2000 Jan; 117(1):25-30. PubMed ID: 10631194 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients. Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043 [TBL] [Abstract][Full Text] [Related]
18. Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model. Prizant H; Taya M; Lerman I; Light A; Sen A; Mitra S; Foster TH; Hammes SR Endocr Relat Cancer; 2016 Apr; 23(4):265-80. PubMed ID: 26880751 [TBL] [Abstract][Full Text] [Related]
19. Extrapulmonary lymphangioleiomyomatosis presented as the asymptomatic retroperitoneal tumours--two cases report. Słodkowska J; Patera J; Breborowicz J; Jarzemska A; Korzeniewska-Kosela M; Siemiatkowska K; Radzikowska E; Przybylski G; Kozłowski W Pol J Pathol; 2006; 57(4):205-7. PubMed ID: 17285764 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary lymphangioleiomyomatosis followed by a localized retroperitoneal lymphangioleiomyoma. Tai HC; Lin JW; Wang YH; Eng HL; Lu HI; Liu YW; Huang CC APMIS; 2006 Nov; 114(11):821-4. PubMed ID: 17078865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]